NO179322C - Analogifremgangsmåte ved fremstilling av terapeutisk aktive diaminforbindelser - Google Patents

Analogifremgangsmåte ved fremstilling av terapeutisk aktive diaminforbindelser

Info

Publication number
NO179322C
NO179322C NO930328A NO930328A NO179322C NO 179322 C NO179322 C NO 179322C NO 930328 A NO930328 A NO 930328A NO 930328 A NO930328 A NO 930328A NO 179322 C NO179322 C NO 179322C
Authority
NO
Norway
Prior art keywords
group
represent
different
same
cerebral
Prior art date
Application number
NO930328A
Other languages
English (en)
Norwegian (no)
Other versions
NO179322B (no
NO930328D0 (no
NO930328L (no
Inventor
Seiichi Sato
Kiyoshi Kawamura
Yoshio Takahashi
Koichiro Watanabe
Sadahiro Shimizu
Tomio Ohta
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of NO930328D0 publication Critical patent/NO930328D0/no
Publication of NO930328L publication Critical patent/NO930328L/no
Publication of NO179322B publication Critical patent/NO179322B/no
Publication of NO179322C publication Critical patent/NO179322C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/49—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO930328A 1989-05-30 1993-01-29 Analogifremgangsmåte ved fremstilling av terapeutisk aktive diaminforbindelser NO179322C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1136652A JP2722250B2 (ja) 1989-05-30 1989-05-30 新規なジアミン化合物及びこれを含有する脳機能障害改善剤
PCT/JP1990/000970 WO1992002487A1 (fr) 1989-05-30 1990-07-30 Nouveau compose de diamine et agent de protection contre les lesions cerebrales contenant un tel compose

Publications (4)

Publication Number Publication Date
NO930328D0 NO930328D0 (no) 1993-01-29
NO930328L NO930328L (no) 1993-01-29
NO179322B NO179322B (no) 1996-06-10
NO179322C true NO179322C (no) 1996-09-18

Family

ID=15180337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930328A NO179322C (no) 1989-05-30 1993-01-29 Analogifremgangsmåte ved fremstilling av terapeutisk aktive diaminforbindelser

Country Status (14)

Country Link
US (1) US5389630A (de)
EP (1) EP0541798B1 (de)
JP (1) JP2722250B2 (de)
KR (1) KR0171569B1 (de)
AT (1) ATE130842T1 (de)
CA (1) CA2087604C (de)
DE (1) DE69023928T2 (de)
DK (1) DK0541798T3 (de)
ES (1) ES2081996T3 (de)
FI (1) FI112649B (de)
HU (1) HU220592B1 (de)
NO (1) NO179322C (de)
RU (1) RU2045522C1 (de)
WO (1) WO1992002487A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE404201T1 (de) * 1992-06-22 2008-08-15 Univ California Glycinrezeptorantagonisten und ihre verwendung
DE4314962A1 (de) * 1993-05-06 1994-11-10 Bayer Ag Substituierte Piperazine
CA2168264A1 (en) * 1993-07-28 1995-02-09 Yoichi Kawashima Novel 1, 4-(diphenylalkyl)piperazine derivatives
US6017953A (en) * 1993-12-28 2000-01-25 Allergan Sales, Inc. Thromboxane ligands
KR100327270B1 (ko) * 1994-01-14 2002-08-01 닛뽕쇼지가부시끼가이샤 디아자시클로알킨알킬술폰아미드유도체
US5602123A (en) 1994-11-02 1997-02-11 Kowa Co., Ltd. Therapeutic agent for myocardial ischemic damages or reperfusion
US5849737A (en) * 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
US5755237A (en) * 1995-06-07 1998-05-26 Rodriguez; Victorio C. Therapeutic use of acetazolamide for the treatment of brain edema
US5944021A (en) * 1995-06-07 1999-08-31 Rodriguez; Victorio C. Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema
JP3808921B2 (ja) * 1995-11-20 2006-08-16 興和株式会社 細胞接着阻害剤
US6462034B1 (en) 1998-04-03 2002-10-08 Theravance, Inc. Local anesthetic compounds and uses
CO5040088A1 (es) 1998-04-03 2001-05-29 Advanced Medicine Inc Nuevos compuestos y usos anestesicos locales
SG83735A1 (en) * 1999-07-03 2001-10-16 Advanced Medicine Inc Novel local anesthetic compounds and uses
US6355637B1 (en) 1999-10-01 2002-03-12 Advanced Medicine, Inc. Local anesthetic compounds
WO2007021545A2 (en) * 2005-08-09 2007-02-22 M's Science Corporation Piperazine derivatives
HUP0500886A2 (en) * 2005-09-23 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use
HUP0500879A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
EP1931620A1 (de) * 2005-09-22 2008-06-18 Sanofi-Aventis Aminoalkylamidderivate als liganden des ccr3-rezeptors
HUP0500877A2 (en) * 2005-09-22 2007-05-29 Sanofi Aventis Amide derivatives as ccr3 receptor ligands, process for producing them, pharmaceutical compositions containing them and their use and intermediates
MX2008007753A (es) * 2005-12-16 2009-02-04 Neuropharma Sa Derivados de dibenceno como bloqueantes del canal de calcio.
AU2007210251A1 (en) 2006-01-27 2007-08-09 M's Science Corporation Piperidine and piperazine derivatives
AU2007215211B2 (en) 2006-02-14 2010-08-26 Eastern Virginia Medical School Methoxypolyethylene glycol thioester chelate and uses thereof
WO2012176878A1 (ja) * 2011-06-23 2012-12-27 学校法人自治医科大学 プロテアソーム阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5732255A (en) * 1980-08-05 1982-02-20 Kowa Co Trimethoxyphenyl derivative
US4661481A (en) * 1983-06-16 1987-04-28 Boehringer Ingelheim Pharmaceuticals, Inc Substituted phenylalkylhomopiperazinylpropyl(ureas or thioureas) useful for treatment of immulogical, inflammatory and allergic disorders
CS244821B2 (en) * 1983-06-16 1986-08-14 Boehringer Ingelheim Ltd Production method of new substituted phenylalkyl(piperazinyl or homopiperazinyle)-prpylureas or thioureas
DE3403778A1 (de) * 1984-02-03 1985-08-08 Degussa Ag, 6000 Frankfurt Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amin seine verwendung zur herstellung von 1-(3-hydroxy-propyl)-1,4-diazepan und 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-diazepan
JP2556722B2 (ja) * 1988-02-18 1996-11-20 興和株式会社 新規なスルホンアミド化合物

Also Published As

Publication number Publication date
FI112649B (fi) 2003-12-31
JPH032144A (ja) 1991-01-08
KR0171569B1 (ko) 1999-05-01
EP0541798A1 (de) 1993-05-19
EP0541798A4 (de) 1994-04-13
HUT63143A (en) 1993-07-28
ES2081996T3 (es) 1996-03-16
DE69023928D1 (de) 1996-01-11
JP2722250B2 (ja) 1998-03-04
DE69023928T2 (de) 1996-04-18
AU647034B2 (en) 1994-03-17
AU6056590A (en) 1992-03-02
NO179322B (no) 1996-06-10
FI930360A0 (fi) 1993-01-28
EP0541798B1 (de) 1995-11-29
WO1992002487A1 (fr) 1992-02-20
FI930360A (fi) 1993-01-28
CA2087604C (en) 2000-04-18
HU9300228D0 (en) 1993-04-28
ATE130842T1 (de) 1995-12-15
US5389630A (en) 1995-02-14
RU2045522C1 (ru) 1995-10-10
NO930328D0 (no) 1993-01-29
HU220592B1 (hu) 2002-03-28
DK0541798T3 (da) 1995-12-27
NO930328L (no) 1993-01-29

Similar Documents

Publication Publication Date Title
NO179322C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive diaminforbindelser
RU93005056A (ru) Новое диаминовое соединение и церебральное защитное лекарственное средство на его основе
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
DE69326395D1 (de) Spirooxathiolan-quinuclidin-Derivat zur Behandlung des Sjögren-Syndroms
ES2110977T3 (es) Espiro-isoquinolein-pirrolidinas y analogos de las mismas, utiles como inhibidores de la aldosa-reductasa.
EP0149487A3 (en) New cephem compounds, process for preparation thereof and pharmaceutical compositions containing them
FI834791A (fi) Foerfarande foer framstaellning av pyrinderivat.
KR960022476A (ko) 디페닐 디설파이드 화합물
FI834793A (fi) Foerfarande foer framstaellning av piperidinderivat.
DE69016266D1 (de) Aminoketonverbindungen.
ATE136904T1 (de) Neue peptidderivate und deren pharmazeutischer gebrauch
FR2823749B1 (fr) Phenyl- et pyridyl-piperidines, procede pour leur preparation et compositions pharmaceutiques les contenant
DK0823254T3 (da) Hidtil ukendt anvendelse af pyrazolopyridinforbindelser
DK0420464T3 (da) 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser